Intellia Therapeutics Inc buy BiotechBee
Start price
24.06.23
/
50%
€38.49
Target price
31.03.26
€50.00
Performance (%)
-41.15%
Price
17:02
€22.65
Summary
This prediction is currently active. The BUY prediction by BiotechBee for Intellia Therapeutics Inc is performing very badly with a performance of -41.15%. This prediction currently runs until 31.03.26. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intellia Therapeutics Inc | 4.885% | 4.885% |
iShares Core DAX® | 4.015% | 2.971% |
iShares Nasdaq 100 | 2.755% | 0.503% |
iShares Nikkei 225® | -0.826% | -5.057% |
iShares S&P 500 | 2.330% | 0.720% |
According to BiotechBee what are the pros and cons of Intellia Therapeutics Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Buy mit Kursziel 50,0